Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,269

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,852

Class I recallsReasonable probability of serious health consequences

24,397

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,085 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/family-farmstead-dairy-announces-recall-raw-mild-cheddar-cheese-due-potential-e-coli-o157h7Published October 15, 2026

Most affected stateHawaii 200 recalls mention this state

State: VI ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 16, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

FDA Recall OngoingHistorical recordClass II

Atomoxetine Capsules, USP, 60 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-759-01.

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Atomoxetine Capsules, USP, 40 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-758-01.

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-757-01.

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-756-01.

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Atomoxetine Capsules, USP, 10 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-755-01.

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Atomoxetine Capsules, USP, 100 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-271-30.

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-270-30.

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Atomoxetine Capsules, USP, 60 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-269-30.

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Atomoxetine Capsules, USP, 40 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-268-30.

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-267-30.

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-266-30.

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Atomoxetine Capsules, USP, 10 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-265-30.

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass I

Phenylephrine HCl Injection, USP 100 mg/10 mL (10 mg/mL) vials, Rx only, Pharmacy Bulk Package (supplied as a single unit), Dist. by: Provepharm, Inc., Collegeville, PA 19426

by Provepharm Inc.

Reason: Presence of Particulate Matter.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN 38478, Manufactured by: Amneal Pharmaceuticals of NY, LLC, NY 11719, NDC 42291-778-90

by AvKARE

Reason: Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lorazepam Tablets, USP, 2mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-906 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6009-61.

by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Reason: Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lorazepam Tablets, USP, 1mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-905 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6008-61.

by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Reason: Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-904 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6007-61

by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Reason: Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: May 28, 2025Historical recordClass II

Feel Good Foods Inc

Product: Feel Good Foods; Three Cheese Mac & Cheese Bites; NET WT 8oz…
Reason: Foreign object (metal pieces).
Published: February 26, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15

by AvKARE

Reason: Out of Specification for Dissolution
Published: February 19, 2025
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: July 22, 2025Historical recordClass I

Wismettac Asian Foods, Inc.

Product: Front Panel: Shirakiku brand, CURVEE PUFFS CORN PUFF SNACK,…
Reason: Undeclared allergen (Milk) in Shirakiku brand Curvee Puffs Corn Puff Snack
Published: February 19, 2025
Distribution: Nationwide

View recall →

Data last updated: October 16, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.